Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia.

Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fernández-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ.

Gastrointest Endosc. 2019 Feb;89(2):247-256.e4. doi: 10.1016/j.gie.2018.09.032. Epub 2018 Oct 3.

PMID:
30291849
2.

Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett's Oesophagus amongst Non-expert Endoscopists.

Sehgal V, Rosenfeld A, Graham DG, Lipman G, Bisschops R, Ragunath K, Rodriguez-Justo M, Novelli M, Banks MR, Haidry RJ, Lovat LB.

Gastroenterol Res Pract. 2018 Aug 29;2018:1872437. doi: 10.1155/2018/1872437. eCollection 2018.

3.

A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix.

Zheng SC, Webster AP, Dong D, Feber A, Graham DG, Sullivan R, Jevons S, Lovat LB, Beck S, Widschwendter M, Teschendorff AE.

Epigenomics. 2018 Jul;10(7):925-940. doi: 10.2217/epi-2018-0037. Epub 2018 Apr 25.

4.

Advances in upper gastrointestinal endoscopy.

Graham DG, Banks MR.

F1000Res. 2015 Dec 16;4. pii: F1000 Faculty Rev-1457. doi: 10.12688/f1000research.6961.1. eCollection 2015. Review.

5.

Guidance for researchers developing and conducting clinical trials in practice-based research networks (PBRNs).

Dolor RJ, Schmit KM, Graham DG, Fox CH, Baldwin LM.

J Am Board Fam Med. 2014 Nov-Dec;27(6):750-8. doi: 10.3122/jabfm.2014.06.140166.

6.

Effectiveness of 2 methods of promoting physical activity, healthy eating, and emotional well-being with the americans in motion--healthy interventions approach.

Pace WD, Lanigan AM, Staton EW, Graham DG, Manning BK, Dickinson LM, Emsermann CB, Stewart EE.

Ann Fam Med. 2013 Jul-Aug;11(4):371-80. doi: 10.1370/afm.1516.

7.

Learning the hard way: the importance of accurate data.

Lewis RS, Graham DG, Watson JD, Lunniss PJ.

Colorectal Dis. 2012 Aug;14(8):1015-8. doi: 10.1111/j.1463-1318.2012.02981.x.

PMID:
22329923
8.

Thinking outside the box: Aboriginal people's suggestions for conducting health studies with Aboriginal communities.

Maar MA, Lightfoot NE, Sutherland ME, Strasser RP, Wilson KJ, Lidstone-Jones CM, Graham DG, Beaudin R, Daybutch GA, Dokis BR, Lesage MT, Raymond M, Williamson P.

Public Health. 2011 Nov;125(11):747-53. doi: 10.1016/j.puhe.2011.08.006.

PMID:
22093920
9.

Institutional Review Board Approval of Practice-based Research Network Patient Safety Studies.

Graham DG, Pace W, Kappus J, Holcomb S, Galliher JM, Duclos CW, Bonham AJ.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 3: Implementation Issues). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

10.

It takes two: using coleaders to champion improvements in small primary care practices.

Gallagher K, Nutting PA, Nease DE Jr, Graham DG, Bonham AJ, Dickinson WP, Main DS.

J Am Board Fam Med. 2010 Sep-Oct;23(5):632-9. doi: 10.3122/jabfm.2010.05.090198.

11.

Sustainability of depression care improvements: success of a practice change improvement collaborative.

Nease DE Jr, Nutting PA, Graham DG, Dickinson WP, Gallagher KM, Jeffcott-Pera M.

J Am Board Fam Med. 2010 Sep-Oct;23(5):598-605. doi: 10.3122/jabfm.2010.05.090212.

12.

Practice-based research network studies and institutional review boards: two new issues.

Yawn BP, Graham DG, Bertram SL, Kurland MJ, Dietrich AJ, Wollan PC, Brandt EC, Huff JM, Pace WD.

J Am Board Fam Med. 2009 Jul-Aug;22(4):453-60. doi: 10.3122/jabfm.2009.04.080168.

13.

Mitigation of patient harm from testing errors in family medicine offices: a report from the American Academy of Family Physicians National Research Network.

Graham DG, Harris DM, Elder NC, Emsermann CB, Brandt E, Staton EW, Hickner J.

Qual Saf Health Care. 2008 Jun;17(3):201-8. doi: 10.1136/qshc.2007.022566.

PMID:
18519627
14.

Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network.

Hickner J, Graham DG, Elder NC, Brandt E, Emsermann CB, Dovey S, Phillips R.

Qual Saf Health Care. 2008 Jun;17(3):194-200. doi: 10.1136/qshc.2006.021915.

PMID:
18519626
15.

Inducing sustainable improvement in depression care in primary care practices.

Nease DE Jr, Nutting PA, Dickinson WP, Bonham AJ, Graham DG, Gallagher KM, Main DS.

Jt Comm J Qual Patient Saf. 2008 May;34(5):247-55.

PMID:
18491688
16.

Strategies for planning and launching PBRN research studies: a project of the Academy of Family Physicians National Research Network (AAFP NRN).

Graham DG, Spano MS, Stewart TV, Staton EW, Meers A, Pace WD.

J Am Board Fam Med. 2007 Mar-Apr;20(2):220-8. Review.

17.
18.

Identification of a new urinary metabolite of carbon disulfide using an improved method for the determination of 2-thioxothiazolidine-4-carboxylic acid.

Amarnath V, Amarnath K, Graham DG, Qi Q, Valentine H, Zhang J, Valentine WM.

Chem Res Toxicol. 2001 Sep;14(9):1277-83.

PMID:
11559044
19.

Dopamine mercapturate can augment dopaminergic neurodegeneration.

Montine TJ, Amarnath V, Picklo MJ, Sidell KR, Zhang J, Graham DG.

Drug Metab Rev. 2000 Aug-Nov;32(3-4):363-76. Review.

PMID:
11139134
20.
21.

Carbon disulfide.

Graham DG.

Environ Health Perspect. 2000 Mar;108(3):A110-2. No abstract available.

22.

Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease.

Zhang J, Kravtsov V, Amarnath V, Picklo MJ, Graham DG, Montine TJ.

J Neurochem. 2000 Mar;74(3):970-8.

23.

Neurotoxicants and the cytoskeleton.

Graham DG.

Curr Opin Neurol. 1999 Dec;12(6):733-7. Review.

PMID:
10676757
24.

Characterization of carbon disulfide neurotoxicity in C57BL6 mice: behavioral, morphologic, and molecular effects.

Sills RC, Valentine WM, Moser V, Graham DG, Morgan DL.

Toxicol Pathol. 2000 Jan-Feb;28(1):142-8.

PMID:
10669001
26.

High-pressure liquid chromatography quantitation of cytochrome c using 393 nm detection.

Picklo MJ, Zhang J, Nguyen VQ, Graham DG, Montine TJ.

Anal Biochem. 1999 Dec 15;276(2):166-70.

PMID:
10603239
27.

Endogenous catechol thioethers may be pro-oxidant or antioxidant.

Picklo MJ, Amarnath V, Graham DG, Montine TJ.

Free Radic Biol Med. 1999 Aug;27(3-4):271-7.

PMID:
10468198
28.

Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice.

Montine TJ, Montine KS, Olson SJ, Graham DG, Roberts LJ 2nd, Morrow JD, Linton MF, Fazio S, Swift LL.

Exp Neurol. 1999 Jul;158(1):234-41.

PMID:
10448437
29.

Exposure of C57BL/6 mice to carbon disulfide induces early lesions of atherosclerosis and enhances arterial fatty deposits induced by a high fat diet.

Lewis JG, Graham DG, Valentine WM, Morris RW, Morgan DL, Sills RC.

Toxicol Sci. 1999 May;49(1):124-32.

PMID:
10367350
30.
31.

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.

Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ.

Am J Pathol. 1999 May;154(5):1423-9.

32.

4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites.

Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ.

J Neurochem. 1999 Apr;72(4):1617-24.

33.

Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures.

Zhang J, Price JO, Graham DG, Montine TJ.

Biochem Biophys Res Commun. 1998 Jul 30;248(3):812-6.

PMID:
9704010
34.

Carbon disulfide and N,N-diethyldithiocarbamate generate thiourea cross-links on erythrocyte spectrin in vivo.

Erve JC, Amarnath V, Graham DG, Sills RC, Morgan AL, Valentine WM.

Chem Res Toxicol. 1998 May;11(5):544-9.

PMID:
9585486
36.

Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy.

Amarnath V, Valentine WM, Montine TJ, Patterson WH, Amarnath K, Bassett CN, Graham DG.

Chem Res Toxicol. 1998 Apr;11(4):317-28.

PMID:
9548802
37.

Carbon disulfide neurotoxicity in rats: VIII. Summary.

Harry GJ, Graham DG, Valentine WM, Morgan DL, Sills RC.

Neurotoxicology. 1998 Feb;19(1):159-61. No abstract available.

PMID:
9498231
38.

Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord.

Sills RC, Harry GJ, Morgan DL, Valentine WM, Graham DG.

Neurotoxicology. 1998 Feb;19(1):117-27.

PMID:
9498228
39.

Covalent modification of hemoglobin by carbon disulfide: III. A potential biomarker of effect.

Valentine WM, Amarnath V, Amarnath K, Erve JC, Graham DG, Morgan DL, Sills RC.

Neurotoxicology. 1998 Feb;19(1):99-107.

PMID:
9498226
40.

Release of carbon disulfide is a contributing mechanism in the axonopathy produced by N,N-diethyldithiocarbamate.

Johnson DJ, Graham DG, Amarnath V, Amarnath K, Valentine WM.

Toxicol Appl Pharmacol. 1998 Feb;148(2):288-96.

PMID:
9473537
41.

Neurotoxicity of endogenous cysteinylcatechols.

Montine TJ, Picklo MJ, Amarnath V, Whetsell WO Jr, Graham DG.

Exp Neurol. 1997 Nov;148(1):26-33.

PMID:
9398447
42.

Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Montine KS, Olson SJ, Amarnath V, Whetsell WO Jr, Graham DG, Montine TJ.

Am J Pathol. 1997 Feb;150(2):437-43.

43.
44.

CS2-mediated cross-linking of erythrocyte spectrin and neurofilament protein: dose response and temporal relationship to the formation of axonal swellings.

Valentine WM, Amarnath V, Graham DG, Morgan DL, Sills RC.

Toxicol Appl Pharmacol. 1997 Jan;142(1):95-105.

PMID:
9007038
45.

The measurement of 2-thiothiazolidine-4-carboxylic acid as an index of the in vivo release of CS2 by dithiocarbamates.

Johnson DJ, Graham DG, Amarnath V, Amarnath K, Valentine WM.

Chem Res Toxicol. 1996 Jul-Aug;9(5):910-6.

PMID:
8828929
46.

Crosslinking of apolipoprotein E by products of lipid peroxidation.

Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ.

J Neuropathol Exp Neurol. 1996 Feb;55(2):202-10.

PMID:
8786379
47.

E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.

Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG.

Am J Pathol. 1996 Jan;148(1):89-93.

48.

Science funding. The National Advisory Environmental Health Sciences Council.

Barfield NC, Buffler PA, Graham DG, Gray-Little B, Greenberger P, Guzelian PS, Henderson M, Henderson R, Jones L, Lieberman M, et al.

Environ Health Perspect. 1995 Nov;103(11):984-5. No abstract available.

49.

Dialkyldithiocarbamates inhibit tyrosine hydroxylase activity in PC12 cells and in fibroblasts that express tyrosine hydroxylase.

Montine TJ, Underhill TM, Valentine WM, Graham DG.

Neurodegeneration. 1995 Sep;4(3):283-90.

PMID:
8581560
50.

The effect of acrylamide and other sulfhydryl alkylators on the ability of dynein and kinesin to translocate microtubules in vitro.

Martenson CH, Odom A, Sheetz MP, Graham DG.

Toxicol Appl Pharmacol. 1995 Jul;133(1):73-81.

PMID:
7597712

Supplemental Content

Loading ...
Support Center